TCIM
MED icon

TIAA CREF Investment Management’s Medifast MED Stock Holding History

TIAA CREF Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.85M Sell
22,306
-8,480
-28% -$1.08M ﹤0.01% 1802
2018
Q4 		$3.85M Sell
30,786
-44,754
-59% -$7.66M ﹤0.01% 1541
2018
Q3 		$16.7M Sell
75,540
-53,165
-41% -$10.8M 0.01% 814
2018
Q2 		$20.6M Sell
128,705
-30,225
-19% -$3.86M 0.01% 725
2018
Q1 		$14.9M Buy
158,930
+6,423
+4% +$480K 0.01% 900
2017
Q4 		$10.6M Buy
152,507
+30,593
+25% +$2.03M 0.01% 1102
2017
Q3 		$7.24M Buy
121,914
+49,413
+68% +$2.46M ﹤0.01% 1381
2017
Q2 		$3.01M Sell
72,501
-38,730
-35% -$1.68M ﹤0.01% 1922
2017
Q1 		$4.93M Sell
111,231
-4,567
-4% -$197K ﹤0.01% 1598
2016
Q4 		$4.82M Sell
115,798
-12,489
-10% -$503K ﹤0.01% 1631
2016
Q3 		$4.85K Buy
128,287
+14,995
+13% +$538K ﹤0.01% 1631
2016
Q2 		$3.77M Buy
113,292
+28,848
+34% +$931K ﹤0.01% 1741
2016
Q1 		$2.55M Buy
84,444
+8,220
+11% +$240K ﹤0.01% 1942
2015
Q4 		$2.32M Sell
76,224
-1,862
-2% -$55.5K ﹤0.01% 2052
2015
Q3 		$2.1M Buy
78,086
+5,811
+8% +$169K ﹤0.01% 2108
2015
Q2 		$2.34M Sell
72,275
-8,031
-10% -$255K ﹤0.01% 2204
2015
Q1 		$2.41M Sell
80,306
-9,501
-11% -$302K ﹤0.01% 2121
2014
Q4 		$3.01M Sell
89,807
-3,120
-3% -$97.2K ﹤0.01% 1970
2014
Q3 		$3.05M Buy
92,927
+5,802
+7% +$178K ﹤0.01% 1943
2014
Q2 		$2.65M Sell
87,125
-45,076
-34% -$1.4M ﹤0.01% 2130
2014
Q1 		$3.85M Sell
132,201
-1,310
-1% -$35.1K ﹤0.01% 1811
2013
Q4 		$3.49M Sell
133,511
-5,241
-4% -$134K ﹤0.01% 1894
2013
Q3 		$3.73M Sell
138,752
-8,123
-6% -$217K ﹤0.01% 1801
2013
Q2 		$3.78M Buy
+146,875
New +$3.86M ﹤0.01% 1733

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

TIAA CREF Investment Management's MED Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Medifast (MED) stake by 28% in Q1 2019, selling an estimated $1.08M and leaving 22,306 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

TIAA CREF Investment Management first reported a position in MED in Q2 2013 and has held it in 24 quarters since. The position peaked at $20.6M in Q2 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • TIAA CREF Investment Management held 22,306 shares of Medifast worth $2.85M as of Q1 2019.
  • TIAA CREF Investment Management sold 8,480 Medifast shares in Q1 2019, an estimated $1.08M.
  • Medifast made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1802 holding.
  • TIAA CREF Investment Management first reported a position in Medifast in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Medifast position peaked at $20.6M in Q2 2018.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.